SCHEMBL26833508

SCHEMBL26833508

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7ccc8ncncc8c7)cc6)c6ccc(-c7ccc8ncncc8c7)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.58
▸ PIK3CA P42336 3/20 0.58
▸ EGFR P00533 6/20 0.48
▸ TDO2 P48775 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.42
▸ PIK3CB P42338 2/20 0.40
▸ MTOR P42345 2/20 0.40
▸ PIK3CG P48736 2/20 0.40
▸ MAPK9 P45984 1/20 0.40
▸ MAPK10 P53779 1/20 0.40
▸ NPC1 O15118 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CYP17A1 P05093 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ FGFR4 P22455 1/20 0.38
▸ SRC P12931 1/20 0.37
▸ PDGFRB P09619 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833500 0.93 PIK3CD (0.48) PIK3CDPIK3CAEGFRTDO2KDM4E
SCHEMBL26833512 0.86 PDGFRB (0.50) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL26834584 0.85 NPC1 (0.57) KDM4ENPC1POLBRAB9ACYP17A1
SCHEMBL26833448 0.85 PDGFRB (0.50) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL26833563 0.84 PIK3CD (0.44) PIK3CDPIK3CAEGFRTDO2KDM4E
SCHEMBL17691850 0.83 PIK3CD (0.68) PIK3CDPIK3CAEGFRTDO2KDM4E
SCHEMBL26833569 0.82 MAPK9 (0.43) PIK3CDPIK3CAEGFRTDO2KDM4E
SCHEMBL26833454 0.82 CYP17A1 (0.48) PIK3CDTDO2PIK3CBPIK3CGMAPK9
SCHEMBL26833455 0.82 PRKCZ (0.50) PIK3CDTDO2PIK3CBPIK3CGMAPK9
SCHEMBL26833451 0.82 NPC1 (0.50) PIK3CDPIK3CAPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 PIK3CD 3986/4885PIK3CA 2980/4885EGFR 1118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback